Two Sigma Advisers’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,000
Closed -$38.6K 2482
2024
Q1
$38.6K Sell
23,000
-400
-2% -$798 ﹤0.01% 2363
2023
Q4
$41.9K Sell
23,400
-200
-0.8% -$367 ﹤0.01% 2411
2023
Q3
$44.6K Hold
23,600
﹤0.01% 2287
2023
Q2
$34.7K Sell
23,600
-100
-0.4% -$173 ﹤0.01% 2295
2023
Q1
$46.2K Sell
23,700
-800
-3% -$1.9K ﹤0.01% 2457
2022
Q4
$55.1K Sell
24,500
-200
-0.8% -$464 ﹤0.01% 2355
2022
Q3
$60K Sell
24,700
-9,892
-29% -$23.3K ﹤0.01% 2360
2022
Q2
$72K Sell
34,592
-69,226
-67% -$160K ﹤0.01% 2432
2022
Q1
$293K Buy
103,818
+67,318
+184% +$224K ﹤0.01% 2225
2021
Q4
$170K Buy
+36,500
New +$124K ﹤0.01% 2324
2014
Q1
Sell
-39,000
Closed -$198K 2306
2013
Q4
$198K Buy
39,000
+1,300
+3% +$6.35K ﹤0.01% 2136
2013
Q3
$172K Buy
37,700
+14,100
+60% +$70.2K ﹤0.01% 1955
2013
Q2
$121K Buy
+23,600
New +$117K ﹤0.01% 2049

Other funds holding CPIX

Two Sigma Advisers's CPIX Position: Q2 2024 in Review

Two Sigma Advisers sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2024, closing a stake of 23,000 shares — an estimated $38.6K sold.

Two Sigma Advisers first reported a position in CPIX in Q2 2013 and held it in 13 quarters. The position peaked at $293K in Q1 2022. 23 funds tracked by Wall St. Rank hold CPIX as of Q2 2024.

  • Two Sigma Advisers reported no remaining Cumberland Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 23,000 Cumberland Pharmaceuticals shares in Q2 2024, an estimated $38.6K.
  • Two Sigma Advisers first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • Two Sigma Advisers's Cumberland Pharmaceuticals position peaked at $293K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.